Journal of Nutrition OpenSOurce Diets- www.ResearchDiets.com

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lesser, S.
Right arrow Articles by Wolffram, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lesser, S.
Right arrow Articles by Wolffram, S.
© 2004 The American Society for Nutritional Sciences J. Nutr. 134:1508-1511, June 2004

Nutrient Metabolism
Research Communication

Bioavailability of Quercetin in Pigs Is Influenced by the Dietary Fat Content1,2

Stephanie Lesser, Rainer Cermak3 and Siegfried Wolffram

Institute of Animal Nutrition, Physiology and Metabolism, Christian-Albrechts-University Kiel, D-24098 Kiel, Germany

3To whom correspondence should be addressed. E-mail: cermak{at}aninut.uni-kiel.de.


   ABSTRACT
TOP
 ABSTRACT
MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 LITERATURE CITED
 
The flavonol quercetin is one of the most prevalent flavonoids found in edible plants. In this study, the influence of dietary fat on oral bioavailability of quercetin was investigated. Quercetin (30 µmol/kg body weight) was administered either as the lipophilic aglycone or as the more hydrophilic quercetin-3-O-glucoside in test meals differing in fat content (3, 17, or 32 g fat/100 g diet) to growing pigs. Blood samples were drawn repeatedly over a 24-h period and analyzed by HPLC. The main metabolite found in plasma was always conjugated quercetin. Quercetin bioavailability from each diet was always higher from the glucoside than from the aglycone. Irrespective of the chemical form applied, the bioavailability of quercetin was higher in the 17% fat diet compared with the 3% fat diet (P < 0.05). No further effect on bioavailability was observed when the flavonols were administered with diets containing 32% fat. The elimination of quercetin was significantly delayed after its application with fat-enriched diets (P < 0.05). Thus, in addition to the chemical form of the flavonol, the fat content of the diet influences oral bioavailability of quercetin.

KEY WORDS: • flavonoids • bioavailability • quercetin • fat • pigs

The flavonol quercetin is one of the most prevalent flavonoids found in edible plants. In plants and subsequently in plant-derived foods, quercetin is present mainly as glycosides (1,2). It has been shown repeatedly that the sugar moiety is a major determinant governing the intestinal absorption of quercetin (3–6). In addition to the chemical form of the flavonol, the applied vehicle or the composition of the diet seems to have a substantial effect on quercetin bioavailability (7–10). In a previous study by our group, the bioavailability of quercetin from quercetin-3-O-glucoside (Q3G)4 was significantly enhanced when Q3G was administered to pigs in a meal rich in fat and low in carbohydrates, compared with a standard carbohydrate-rich pig diet (3). One reason for this finding could have been the difference in fat concentration in the experimental diets because lipids in combination with emulsifiers were shown to enhance the absorption of orally administered quercetin in rats (8). Therefore, in this study we investigated the effect of the dietary fat content on the oral bioavailability of quercetin in pigs. Quercetin was administered either as the rather lipophilic aglycone or as the more water-soluble Q3G in diets with differing fat contents.


   MATERIALS AND METHODS
TOP
 ABSTRACT
 MATERIALS AND METHODS
RESULTS
 DISCUSSION
 LITERATURE CITED
 
    Animals, diets, and experimental procedure. Cross-bred growing male castrated pigs (n = 7) with a body weight (BW) of 30–35 kg were purchased from a local farmer. The pigs were surgically equipped with permanent catheters (Cook Deutschland GmbH) placed in the jugular vein. They were restrictively fed (80% of voluntary feed intake) a commercial pig diet composed of barley, wheat, and defatted soybean meal (Plambeck Kraftfutter). The composition of this diet (designated as 3% fat diet) is shown in Table 1. Vitamins and minerals were supplemented according to the recommendations of the German Society of Nutritional Physiology (11). Water was freely available by nipple drinkers.


View this table:
[in this window]
[in a new window]
  		TABLE 1 Composition of the diets1

 
Each pig received in consecutive experiments either quercetin aglycone or Q3G (30 µmol/kg BW) mixed into a test meal directly before administration. The test meals consisted either of the regular pig diet (3% fat diet) or of an isoenergetic amount of the same diet enriched with either 15 or 30 g lard/100 g (wt/wt) (designated as the 17 and 32% fat diets, respectively) (Table 1). Lard was obtained from Fischermanns GmbH. Blood samples (8 mL each) were collected over a period of 24 h. After each experiment, there was a wash-out period of 24 h.

    Processing of plasma samples and HPLC analysis. Blood samples were drawn into heparinized containers, immediately centrifuged (1500 x g, 10 min, 4°C) and stored at –70°C until analysis by HPLC as described previously (3,12,13). All samples were treated enzymatically with ß-glucuronidase/sulfatase before the extraction of flavonol compounds.

All flavonols were obtained from Carl Roth GmbH. ß-Glucuronidase/sulfatase type H-2 (crude enzyme extract from Helix pomatia) was purchased from Sigma-Aldrich AG.

    Statistical analysis. The area under the plasma concentration-time curve (AUC) was determined according to the linear trapezoidal rule. For each pig and treatment, total bioavailability (AUCtotal) was calculated by adding up the AUC values of quercetin and its metabolites with an intact flavonol structure (isorhamnetin and tamarixetin). AUC data, maximal plasma concentrations (cmax), those at 480 (c480) and 720 min (c720) after ingestion of the test meal, and time at maximal plasma concentration (tmax) values were analyzed with the MIXED model procedure from SAS (Version 8.2, SAS Institute) based on the model: Yi,j,k = µ + Di + Fj + (D x F)i,j + Ak + ei,j,k where µ = mean, Di = diet (i = 3, 17, or 32% fat diet), Fj = administered flavonol (j = quercetin aglycone or Q3G), (D x F) = diet x administered flavonol interaction, Ak = animal, and ei,j, k = residual error. The individual pig was treated as a random factor. AUC data, cmax, c480, c720 and tmax values are presented as least-squares means (LSM) ± SEM. A P-value < 0.05 was considered significant.


   RESULTS
TOP
 ABSTRACT
 MATERIALS AND METHODS
 RESULTS
DISCUSSION
 LITERATURE CITED
 
Irrespective of the flavonol administered or the diet fed, the main metabolite in plasma after ß-glucuronidase/sulfatase treatment of the samples was always quercetin (78.8 ± 0.8%, n = 38). In addition to quercetin, the monomethylated derivatives isorhamnetin (3'-O-methyl quercetin, 11.0 ± 0.5%) and tamarixetin (4'-O-methyl quercetin, 10.3 ± 0.4%) were found. No differences in the relative abundance of these metabolites were observed after intake of the aglycone or of the glucoside.

After the intake of quercetin aglycone with the 3% fat diet, the mean peak plasma concentration (cmax) was reached ~100 min (tmax) after intake (Table 2). When the flavonol was administered together with the 17 or 32% fat diets, plasma concentrations of quercetin rose more sharply (Fig. 1) and reached their peak levels significantly earlier (Table 2). Thereafter, quercetin levels with the 3% fat diet decreased continuously until they were below the detection limit after 24 h (Fig. 1). The elimination of quercetin was clearly delayed after its application with the fat-enriched diets; 480 min after intake (c480) with the 32% fat diet, the quercetin plasma concentration (0.054 ± 0.011 µmol/L, n = 7) was higher than the value obtained with the 3% fat diet (0.015 ± 0.011 µmol/L, n = 7, P < 0.05). However, the respective plasma concentration obtained with the 17% fat diet (0.050 ± 0.013 µmol/L, n = 6) did not differ from the 3% fat diet value (P = 0.07) or the 32% fat diet value (P = 0.81). The values determined at 720 min after intake (c720) with the 17 and 32% fat diets (0.073 ± 0.016 µmol/L and 0.070 ± 0.015 µmol/L, respectively) were both significantly higher than the corresponding value attained after intake with the 3% fat diet (0.015 ± 0.015 µmol/L, P < 0.05) (Fig. 1). The fat content of the diet had a significant effect on total bioavailability (AUCtotal) of quercetin from the aglycone-containing diets (Table 2). Compared with the 3% fat diet, bioavailability was significantly increased with the fat-enriched diets, with no significant difference between the 17 and 32% fat diets.


View this table:
[in this window]
[in a new window]
  		TABLE 2 Relative bioavailability and pharmacokinetic parameters of quercetin in pigs after intake of quercetin aglycone or quercetin-3-O-glucoside in test meals differing in their fat content1

 


View larger version (23K):
[in this window]
[in a new window]
  		FIGURE 1 Plasma concentration-time curves of quercetin after oral administration of quercetin aglycone or of quercetin-3-O-glucoside (inset) to pigs (30 µmol/kg BW each) in test meals that differed in their fat content. Filled circles represent values for 3% fat diet, open triangles for the 17% fat diet, and open squares for the 32% fat diet (w/w). Data are means ± SEM (n = 6; for quercetin aglycone in the 3 and 32% fat diets, n = 7).

 
After intake of Q3G with the 3% fat diet, the mean peak plasma concentration of quercetin was reached after ~70 min (Table 2). When the flavonol glucoside was administered together with fat-enriched diets, the plasma concentrations of quercetin reached their peak levels earlier, which was significant only for the 32% fat diet. However, the cmax value of plasma quercetin was lowest after intake with 32% fat (Table 2). Similar to what was observed with the diets containing the aglycone, the elimination of quercetin was delayed with the fat-enriched diets (inset Fig. 1). Plasma concentrations after 480 min differed significantly among all 3 diets (0.053 ± 0.020 µmol/L in the 3% fat diet, 0.123 ± 0.020 µmol/L in the 17% fat diet, P < 0.05 vs. 3% fat diet, and 0.174 ± 0.020 µmol/L in the 32% fat diet, P < 0.05 vs. 3% and vs. 17% fat diet, n = 6). The c720 values from both the 17 and 32% fat diets (0.071 ± 0.015 µmol/L and 0.090 ± 0.020 µmol/L, respectively) were also significantly higher than the plasma concentration after intake with the 3% fat diet (0.026 ± 0.015 µmol/L, P < 0.05). Hence, the fat content of the diet had a significant effect on the AUCtotal from Q3G (Table 2). In the case of Q3G intake, the significantly increased AUCtotal values obtained with the fat-enriched diets were due solely to the delayed elimination of quercetin (inset Fig. 1).

The amount of quercetin and methylated quercetin metabolites in the systemic circulation was also significantly influenced by the chemical form of quercetin administered. With quercetin aglycone, the mean total bioavailability from any of the diets was always significantly lower than from the respective diets containing the quercetin glucoside (P < 0.05) (Table 2). The fat content of the diet and the chemical form of the flavonol, however, did not have a significant interaction.


   DISCUSSION
TOP
 ABSTRACT
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
LITERATURE CITED
 
In a recent experiment, total oral bioavailability of quercetin in pigs was increased by 140% when Q3G was administered with meat compared with a standard pig diet (3). One possible explanation for this finding could have been the higher fat concentration of meat. We therefore conducted the present study to investigate the influence of the dietary fat content on the oral bioavailability of quercetin from both quercetin aglycone and Q3G.

In pig plasma, quercetin and its metabolites with a flavonol structure are present in substantial amounts only as conjugates (3,12). Therefore, we treated all plasma samples with ß-glucuronidase/sulfatase to release the flavonol aglycones. In all experiments, quercetin was found in plasma within 30 min after ingestion. This suggests that absorption had already occurred in the upper small intestine, irrespective of the diet and of the flavonol administered.

The increase in the dietary fat content from 3 to 17% crude fat enhanced the total bioavailability of quercetin (quercetin and its metabolites, isorhamnetin and tamarixetin) from the quercetin aglycone containing diet by ~50%. This effect was already maximal because a further increase in dietary fat had no additional effect. It is generally believed that the rather lipophilic quercetin aglycone diffuses passively through the brush border membrane (BBM) of enterocytes (14,15). Azuma et al. (8) observed that coadministration of lipids (soybean oil or lecithin) and emulsifiers such as the bile constituent taurocholate was able to enhance and accelerate the intestinal absorption of quercetin in rats. In another rat study, the absorption of the flavanol catechin was enhanced when green tea catechins were administered as a phospholipid complex rather than as free catechins (16). Thus, it is likely that in the presence of dietary fat, quercetin was partly incorporated into mixed bile salt micelles in the lumen of the duodenum. This could have promoted its solubility and transport through the unstirred water layer and passive diffusion through the BBM.

Interestingly, an enhancing effect of dietary fat on total bioavailability of quercetin was also found after administration of Q3G-containing diets. At first glance, this was an unexpected observation, because the more hydrophilic glucoside of quercetin should not directly interact with the absorption of lipids. In agreement with this finding, Azuma et al. (17) recently observed an enhancement of quercetin bioavailability from quercetin glucosides in onions by administration with at least 4.6% fat. In the present study, the effect of dietary fat on quercetin bioavailability from Q3G was due exclusively to a delayed elimination of quercetin from plasma. In contrast, the addition of fat to the quercetin aglycone–containing diets also enhanced the absorption of the flavonol. Several studies pointed to the involvement of ß-glycosidases such as the BBM enzyme, lactase-phlorizin hydrolase (LPH, EC 3.2.1.62), in the intestinal absorption of Q3G (18–20). According to those studies, Q3G is hydrolyzed by LPH in the small intestine and the liberated aglycone diffuses passively across the BBM into the enterocyte. Because the liberation of quercetin from Q3G by LPH occurs adjacent to the BBM, enhanced solubility and diffusion through the unstirred water layer as promoted by the formation of micelles cannot be expected in this case. However, an enhancing effect of dietary fat on the reabsorption of quercetin during enterohepatic circulation can be expected after the administration of both Q3G and quercetin aglycone. Stimulation of biliary secretion by dietary fat intensifies excretion of quercetin glucuronides and/or sulfates with the bile (21). After microbial deconjugation of the excreted conjugates in the lower small and large intestine, quercetin could be partially reabsorbed (22). This could explain the higher plasma concentrations of quercetin several hours after ingestion with the fat-enriched diets.

The earlier appearance of maximal quercetin plasma concentrations after ingestion with fat could be explained by a partial incorporation of the quercetin conjugates formed in the enterocyte into chylomicrons with consecutive export into the peripheral blood via lymph. Thus, part of the quercetin would bypass the liver and, consequently, increase the plasma concentration. However, because no data are available concerning the incorporation of quercetin conjugates into lipoproteins during absorption, this remains speculative at present.

In our previous study, administration of Q3G together with meat enhanced total quercetin bioavailability by 140% (3), whereas the addition of fat in the present study enhanced bioavailability of Q3G by only ~30%. This suggests that other dietary factors in addition to fat influence the bioavailability of quercetin. It is conceivable that the lack of carbohydrates in the meat could have favored carrier-mediated uptake of Q3G by the intestinal sodium-dependent glucose transporter (SGLT1) (3). Unspecific binding to food components such as soy protein could have limited the absorption of quercetin from the test meal used compared with the meat meal (23). In this regard, it is important to note that the absolute amount of protein in the meat meal was only ~10% of that in the standard meal used (3).

In the present study, all test meals were isoenergetic to avoid differences in the rate of stomach emptying, which in turn would influence absorption kinetics. Hence, the test meals differed inevitably in protein (32, 23, and 16 g crude protein) and carbohydrate content (100, 68, and 48 g nonfiber carbohydrates) in the 3, 17, and 32% fat test meals, respectively. These differences in protein and carbohydrate content were rather small, however, compared with the relative differences in fat content (7, 28, and 43 g crude fat in the 3, 17, and 32% fat test meals, respectively). Thus, in our opinion, it is most likely that the differences in the fat content were responsible for the observed effects on quercetin bioavailability.

Regardless of these latter considerations, Q3G was always more bioavailable than quercetin aglycone with each of the different diets. This observation agrees with our previous study using pigs (3), and is also known from studies of humans (7) and rats (24). Most authors explain the higher bioavailability of Q3G compared with the aglycone by the occurrence of higher local quercetin concentrations adjacent to the BBM due to the Q3G-hydrolyzing activity of LPH (see above). In addition, transport of Q3G by SGLT1 could also contribute to the higher bioavailability of quercetin from Q3G compared with quercetin aglycone. Several studies showed an interaction of Q3G with SGLT1 (5,25,26). A recent study demonstrated transport of a quercetin glucoside by SGLT1 (27). In experiments with pig small intestine BBM vesicles, we also found evidence for transport of Q3G by SGLT1 (28).

In summary, we showed that the dietary fat content influences the bioavailability of quercetin. Bioavailability from both quercetin aglycone and quercetin-3-O-glucoside is enhanced in a diet enriched with fat compared with a low-fat diet. This could be explained by an improved solubility and an accelerated absorption of the lipophilic quercetin aglycone via lipid micelles and a prolonged enterohepatic circulation.


   FOOTNOTES
 
1 Presented in part at the 1st International Conference on Polyphenols and Health, November 18–21, 2003, Vichy, France [Lesser, S., Cermak, R., Schulz, P. & Wolffram, S. (2003) The bioavailability of quercetin in pigs is influenced by the dietary fat content (P90)]. Back

2 Supported by grant no. WO 763/2–2 and Graduiertenkolleg 820 of the Deutsche Forschungsgemeinschaft (DFG). Back

4 Abbreviations used: AUC, area under the curve; BBM, brush border membrane; BW, body weight; c480, c720, plasma concentration at 480 or 720 min after ingestion of test meal, respectively; cmax, maximal plasma concentration; LPH, lactase-phlorizin hydrolase; LSM, least-squares means; Q3G, quercetin-3-O-glucoside; SGLT1, sodium-dependent glucose transporter; tmax, time at maximal plasma concentration. Back

Manuscript received 5 February 2004. Initial review completed 8 March 2004. Revision accepted 26 March 2004.


   LITERATURE CITED
TOP
 ABSTRACT
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 LITERATURE CITED
 

1. Sakakibara, H., Honda, Y., Nakagawa, S., Ashida, H. & Kanazawa, K. (2003) Simultaneous determination of all polyphenols in vegetables, fruits, and teas. J. Agric. Food Chem. 51:571-581.[Medline]

2. Herrmann, K. (1988) On the occurrence of flavonol and flavone glycosides in vegetables. Z. Lebensm. Unters. Forsch. 186:1-5.

3. Cermak, R., Landgraf, S. & Wolffram, S. (2003) The bioavailability of quercetin in pigs depends on the glycoside moiety and on dietary factors. J. Nutr. 133:2802-2807.[Abstract/Free Full Text]

4. Graefe, E. U., Wittig, J., Mueller, S., Riethling, A. K., Uehleke, B., Drewelow, B., Pforte, H., Jacobasch, G., Derendorf, H. & Veit, M. (2001) Pharmacokinetics and bioavailability of quercetin glycosides in humans. J. Clin. Pharmacol. 41:492-499.[Abstract]

5. Gee, J. M., Dupont, M. S., Day, A. J., Plumb, G. W., Williamson, G. & Johnson, I. T. (2000) Intestinal transport of quercetin glycosides in rats involves both deglycosylation and interaction with the hexose transport pathway. J. Nutr. 130:2765-2771.[Abstract/Free Full Text]

6. Hollman, P.C.H., Bijsman, M.N.C.P., van Gameren, Y., Cnossen, E.P.J., de Vries, J.H.M. & Katan, M. B. (1999) The sugar moiety is a major determinant of the absorption of dietary flavonoid glycosides in man. Free Radic. Res. 31:569-573.[Medline]

7. Hollman, P.C.H., van Trijp, J.M.P., Buysman, M.N.C.P., van der Gaag, M. S., Mengelers, M.J.B., de Vries, J.H.M. & Katan, M. B. (1997) Relative bioavailability of the antioxidant flavonoid quercetin from various foods in man. FEBS Lett. 418:152-156.[Medline]

8. Azuma, K., Ippoushi, K., Ito, H., Higashio, H. & Terao, J. (2002) Combination of lipids and emulsifiers enhances the absorption of orally administered quercetin in rats. J. Agric. Food Chem. 50:1706-1712.[Medline]

9. Piskula, M. K. (2000) Factors affecting flavonoids absorption. Biofactors 12:175-180.[Medline]

10. Piskula, M. K. & Terao, J. (1998) Quercetin’s solubility affects its accumulation in rat plasma after oral administration. J. Agric. Food Chem. 46:4313-4317.

11. Ausschuss für Bedarfsnormen der Gesellschaft für Ernährungsphysiologie (1987) Energie- und Nährstoffbedarf landwirtschaftlicher Nutztiere Nr. 4 Schweine 1987 DLG-Verlag, Frankfurt a. M. Germany .

12. Ader, P., Wessmann, S. & Wolffram, S. (2000) Bioavailability and metabolism of the flavonol quercetin in the pig. Free Radic. Biol. Med. 28:1056-1067.[Medline]

13. Hollman, P.C.H., van Trijp, J.M.P. & Buysman, M.N.C.P. (1996) Fluorescence detection of flavonols in HPLC by postcolumn chelation with aluminium. Anal. Chem. 68:3511-3515.

14. Murota, K., Shimizu, S., Chujo, H., Moon, J. H. & Terao, J. (2000) Efficiency of absorption and metabolic conversion of quercetin and its glucosides in human intestinal cell line Caco-2. Arch. Biochem. Biophys. 384:391-397.[Medline]

15. Walgren, R. A., Walle, U. K. & Walle, T. (1998) Transport of quercetin and its glucosides across human intestinal epithelial Caco-2 cells. Biochem. Pharmacol. 55:1721-1727.[Medline]

16. Pietta, P. G., Simonetti, P., Gardana, C., Brusamolino, A., Morazzoni, P. & Bombardelli, E. (1998) Relationship between rate and extent of catechin absorption and plasma antioxidant status. Biochem. Mol. Biol. Int. 46:895-903.[Medline]

17. Azuma, K., Ippoushi, K., Ito, H., Horie, H. & Terao, J. (2003) Enhancing effect of lipids and emulsifiers on the accumulation of quercetin metabolites in blood plasma after the short-term ingestion of onion by rats. Biosci. Biotechnol. Biochem. 67:2548-2555.[Medline]

18. Sesink, A.L.A., Arts, I.C.W., Faassen-Peters, M. & Hollman, P.C.H. (2003) Intestinal uptake of quercetin-3-glucoside in rats involves hydrolysis by lactase phlorizin hydrolase. J. Nutr. 133:773-776.[Abstract/Free Full Text]

19. Németh, K., Plumb, G. W., Berrin, J. G., Juge, N., Jacob, R., Naim, H. Y., Williamson, G., Swallow, D. M. & Kroon, P. A. (2003) Deglycosylation by small intestinal epithelial cell ß-glucosidases is a critical step in the absorption and metabolism of dietary flavonoid glycosides in humans. Eur. J. Nutr. 42:29-42.[Medline]

20. Day, A. J., Cañada, F. J., Díaz, J. C., Kroon, P. A., McLauchlan, R., Faulds, C. B., Plumb, G. W., Morgan, M.R.A. & Williamson, G. (2000) Dietary flavonoid and isoflavone glycosides are hydrolysed by the lactase site of lactase phlorizin hydrolase. FEBS Lett. 468:166-170.[Medline]

21. Ueno, I., Nakano, N. & Hirono, I. (1983) Metabolic fate of [14C]quercetin in the ACI rat. Jpn. J. Exp. Med. 53:41-50.[Medline]

22. Aura, A. M., O’Leary, K. A., Williamson, G., Ojala, M., Bailey, M., Puupponen-Pmiä, R., Nuutila, A. M., Oksman-Caldentey, K. M. & Poutanen, K. (2002) Quercetin derivatives are deconjugated and converted to hydroxyphenylacetic acids but not methylated by human fecal flora in vitro. J. Agric. Food Chem. 50:1725-1730.[Medline]

23. Rawel, H. M., Czajka, D., Rohn, S. & Kroll, J. (2002) Interactions of different phenolic acids and flavonoids with soy proteins. Int. J. Biol. Macromol. 30:137-150.[Medline]

24. Morand, C., Manach, C., Crespy, V. & Rémésy, C. (2000) Quercetin 3-O-ß-glucoside is better absorbed than other quercetin forms and is not present in rat plasma. Free Radic. Res. 33:667-676.[Medline]

25. Wolffram, S., Blöck, M. & Ader, P. (2002) Quercetin-3-glucoside is transported by the glucose carrier SGLT1 across the brush border membrane of rat small intestine. J. Nutr. 132:630-635.[Abstract/Free Full Text]

26. Ader, P., Blöck, M., Pietzsch, S. & Wolffram, S. (2001) Interaction of quercetin glucosides with the intestinal sodium/glucose co-transporter (SGLT-1). Cancer Lett. 162:175-180.[Medline]

27. Walle, T. & Walle, U. K. (2003) The ß-D-glucoside and sodium-dependent glucose transporter 1 (SGLT1)-inhibitor phloridzin is transported by both SGLT1 and multidrug resistance-associated proteins 1/2. Drug Metab. Dispos. 31:1288-1291.[Abstract/Free Full Text]

28. Cermak, R., Landgraf, S. & Wolffram, S. (2004) Quercetin glucosides inhibit glucose uptake into brush-border-membrane vesicles of porcine jejunum. Br. J. Nutr. (in press).




This article has been cited by other articles:


Home page
 J. Nutr.Home page
S. Egert, S. Wolffram, A. Bosy-Westphal, C. Boesch-Saadatmandi, A. E. Wagner, J. Frank, G. Rimbach, and M. J. Mueller
Daily Quercetin Supplementation Dose-Dependently Increases Plasma Quercetin Concentrations in Healthy Humans
J. Nutr., September 1, 2008; 138(9): 1615 - 1621.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Clin. Nutr.Home page
C. E Rufer, A. Bub, J. Moseneder, P. Winterhalter, M. Sturtz, and S. E Kulling
Pharmacokinetics of the soybean isoflavone daidzein in its aglycone and glucoside form: a randomized, double-blind, crossover study
Am. J. Clinical Nutrition, May 1, 2008; 87(5): 1314 - 1323.
[Abstract] [Full Text] [PDF]

Home page
 J. Nutr.Home page
W. Wiczkowski, J. Romaszko, A. Bucinski, D. Szawara-Nowak, J. Honke, H. Zielinski, and M. K. Piskula
Quercetin from Shallots (Allium cepa L. var. aggregatum) Is More Bioavailable Than Its Glucosides
J. Nutr., May 1, 2008; 138(5): 885 - 888.
[Abstract] [Full Text] [PDF]

Home page
 J. Nutr.Home page
J. W. Erdman Jr., D. Balentine, L. Arab, G. Beecher, J. T. Dwyer, J. Folts, J. Harnly, P. Hollman, C. L. Keen, G. Mazza, et al.
Flavonoids and Heart Health: Proceedings of the ILSI North America Flavonoids Workshop, May 31-June 1, 2005, Washington, DC
J. Nutr., March 1, 2007; 137(3): 718S - 737S.
[Abstract] [Full Text] [PDF]

Home page
 J. Nutr.Home page
C. K. Chow
Grape Powder Polyphenols and Atherosclerosis Development
J. Nutr., August 1, 2006; 136(8): 2272 - 2272.
[Full Text] [PDF]

Home page
 J. Nutr.Home page
T. Weangsripanaval, T. Moriyama, T. Kageura, T. Ogawa, and T. Kawada
Dietary Fat and an Exogenous Emulsifier Increase the Gastrointestinal Absorption of a Major Soybean Allergen, Gly m Bd 30K, in Mice
J. Nutr., July 1, 2005; 135(7): 1738 - 1744.
[Abstract] [Full Text] [PDF]

Home page
 J. Nutr.Home page
C.-Y. Chen, P. E. Milbury, K. Lapsley, and J. B. Blumberg
Flavonoids from Almond Skins Are Bioavailable and Act Synergistically with Vitamins C and E to Enhance Hamster and Human LDL Resistance to Oxidation
J. Nutr., June 1, 2005; 135(6): 1366 - 1373.
[Abstract] [Full Text] [PDF]

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lesser, S.
Right arrow Articles by Wolffram, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lesser, S.
Right arrow Articles by Wolffram, S.

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]